744 related articles for article (PubMed ID: 9020332)
1. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
Motoyama K; Arima T; Lehmann M; Flye MW
Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
4. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
5. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
Arima T; Goss JA; Walp LA; Flye MW
Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
[TBL] [Abstract][Full Text] [Related]
6. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
[TBL] [Abstract][Full Text] [Related]
7. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
8. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
9. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
[TBL] [Abstract][Full Text] [Related]
10. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
11. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
[TBL] [Abstract][Full Text] [Related]
12. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
13. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
[TBL] [Abstract][Full Text] [Related]
14. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes.
Nakafusa Y; Goss JA; Flye MW
Surgery; 1993 Aug; 114(2):183-9; discussion 189-90. PubMed ID: 8342124
[TBL] [Abstract][Full Text] [Related]
15. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
16. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
Motoyama K; Lehmann M; Flye MW
Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
[No Abstract] [Full Text] [Related]
17. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
18. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
[TBL] [Abstract][Full Text] [Related]
19. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
Niimi M; Witzke O; Bushell A; Hara M; Morris PJ; Wood KJ
Transplantation; 2000 Nov; 70(10):1524-8. PubMed ID: 11118100
[TBL] [Abstract][Full Text] [Related]
20. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
